ANGELA SMITH: Open Payments
NPI 1568224673 · HATTIESBURG, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,104 in 101 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $2,770 · 2025 $2,104
Food & beverage: $2,086Education: $18
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $656 |
| ACADIA Pharmaceuticals Inc | 9 | $215 |
| SK Life Science, Inc. | 5 | $155 |
| UCB, Inc. | 5 | $154 |
| Lundbeck LLC | 6 | $113 |
| Lilly USA, LLC | 6 | $100 |
| PFIZER INC. | 6 | $99 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| ARGENX US, INC. | 4 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
Products named: QULIPTA, BOTOX, NUPLAZID, REXULTI, UBRELVY, Rystiggo, KISUNLA, NURTEC ODT.
Industry payments across MS — which companies pay providers there.
